Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02106 |
| Species: | Homo sapiens |
| Position : | chr8:23422136-23432636 |
| Year: | 2016 |
| Title: | Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis. |
| Genome Build: | hg18 |
| Enhancer Type: | Super-enhancer |
| Condition: | Normal |
| PMID: | 26766440 |
| Tissue: | bone marrow |
| Tissue Ontology ID: | UBERON:0002371 |
| Cell Source: | Adult bone marrow CD34+-derived proerythroblasts (A5 ProE) |
| Cell Type: | erythroblast |
| Cell Ontology ID: | CL:0000765 |
| Experiment Type: | Super-enhancer profiling; TF binding assay; Functional perturbation assay; Endogenous enhancer perturbation |
| High Throughput Method: | H3K27ac ChIP-seq; H3K4me1 ChIP-seq; GATA1 ChIP-seq; TAL1 ChIP-seq; RNA-seq |
| Low Throughput Method: | Orthologous mouse enhancer CRISPR/Cas9 deletion; ChIP-qPCR; RT-qPCR; CRISPR-Cas9 endogenous deletion/editing |
| Target gene : | SLC25A37 |
| TF name : | TAL1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02105 | chr8:23422136-23432636 | bone marrow | erythroblast | NA |